News

Josep Dalmau receives the Camillo Golgi Award from the European Academy of Neurology

IDIBAPS creates three multidisciplinary research programs to encourage collaboration among its groups

They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the Lym1

First genetic marker for Multiple Sclerosis severity identified

This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.

Josep Dalmau receives the “Scientific Breakthrough 2023” Award from the American Brain Foundation

The accolade recognises the commitment of this Clínic Barcelona-IDIBAPS researcher to deepening our understanding of autoimmune neurological diseases1

Preview of the documentary Mirar al miedo [Looking at Fear], about a patient with encephalitis

On Friday, February 17, a preview was screened of the film, directed by Javier García Gómez, which tells the true story of Marta Huertas, a patient w1